title: Pre- and post-treatment serum ferritin levels in patients with higher risk myelodysplastic syndromes receiving azacitidine.
authors.affiliation: a Faculty of Medicine , University of British Columbia , Vancouver , BC , Canada ;
authors.forename: Erica
authors.initials: E
authors.lastname: Tsang
authors.affiliation: b Department of Hematology , St. Paul's Hospital and the University of British Columbia , Vancouver , BC , Canada.
authors.forename: Heather A
authors.initials: HA
authors.lastname: Leitch
mesh_terms: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine; D005293:Ferritins; D006801:Humans; D015470:Leukemia, Myeloid, Acute; D009190:Myelodysplastic Syndromes; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D005293:Ferritins; D001374:Azacitidine